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Abstract
Background: Reproductive failure, determined as recurrent spontaneous abortions (RSA) or recurrent implantation 
failure (RIF) in women is not well understood. Several factors, including embryo quality, and cellular and molecular 
changes in endometrium may contribute to the insufficient feto-maternal interaction resulting in reproductive failure. 
Prior clinical studies suggest an inadequate endometrial growth and development of the endometrium, leading to a 
lesser endometrial thickness.
Methods: We therefore aimed to determine the cellular proliferation using Ki67, and the expression of markers of 
vascularisation, such as factor VIII (a marker of endothelial cells) and smooth muscle cell actin (SMCA; a marker of 
pericytes and smooth muscle cells) in endometrium of healthy women and women with RSA or RIF. LH-dated mid-
secretory endometrial biopsies of seven healthy women and twenty women with reproductive failure were examined 
via immunohistochemistry followed by image analysis.
Results: Cellular proliferation but not expression of factor VIII or SMCA was decreased (P < 0.0004) in endometrium of 
women with RSA and RIF compared to healthy controls. Conclusion: Our data indicate that reproductive failure is due 
to insufficient cell proliferation/tissue growth rather than inadequate vascularisation in the endometrium.
Background
Reproductive failure comprises idiopathic recurrent
spontaneous abortions (RSA) as well as recurrent
implantation failure (RIF) [1]. One of the current RIF def-
inition is a failure to conceive after three transfers of one
or more good quality embryos; however, this definition
may vary depending on the center [2]. On the other hand,
idiopathic RSA is defined as three or more consecutive
pregnancy losses within the first 20 weeks of gestation
after exclusion of known contributing factors including
uterine malformations, bleeding abnormalities, hormone
disequilibrium, parental chromosomal defects, infec-
tions and others [3].
Adequate implantation is a limiting factor in human
reproduction. Despite major improvement in assisted
reproduction techniques (ART) the clinical pregnancy
rate per embryo transfer in fresh ART cycles is 31%, and
up to 41% in oocyte donation programs [4]. A number of
etiologies, including decreased embryonic quality, endo-
metrial receptivity, feto-maternal communication, endo-
crine, genetic and other factors have been suggested as
causes for reproductive failure [5-7]. Even though intra-
uterine endometrium is not essential for embryo implan-
tation, since ectopic pregnancies occur [8], several
studies indicated an altered endometrial function in
women with reproductive failure [9,10]. Changes at the
cellular and molecular level in endometrium from
women with reproductive failure have been reported
[8,11,12]; suggesting an impact of specific genes on the
success of implantation. However, these studies deter-
mine mostly gene expression profiles and only partially
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has been recognized as a possible factor in reproductive
failures [11,13-15], limited data is available concerning
endometrial cell proliferation and its regulation. Further-
more, inconsistent results were obtained from studies of
the role of endometrial vascularisation, angiogenesis,
blood flow and/or endometrial thickness in women with
implantation failure; while some studies demonstrate dif-
ferences between normal and reproductive failures sub-
jects others do not [16-19].
We hypothesized that reproductive failures are due to
altered uterine growth caused by changes in cell prolifer-
ation and vascularisation/angiogenesis in the endome-
trium. Therefore, the aim of this study was to examine
cellular proliferation and expression of markers of vascu-
larisation (factor VIII and smooth muscle cell actin
[SMCA]) at the protein level in endometrial biopsies
from the mid-secretory phase of healthy women and
women with reproductive failure.
Methods
In this observational, non-therapeutic pilot study, endo-
metrial biopsies were taken after informed consent
according to the Ethical Committee of the University of
Heidelberg, Germany. A total of 27 women, at age 25 to
42 years, who were not on any hormonal treatments were
included in this study. All women exhibited regular 28 ± 1
day cycles. Pipelle biopsies were taken in the mid-secre-
tory phase on day 8-9 after the LH surge (LH +8/+9) from
11 women with RIF, 9 women with RSA, and 7 healthy
woman. RIF was defined by failure to detect a positive
serum hCG after three transfers of two or three good
quality embryos created through in vitro fertilization.
RSA was defined as the appearance of three or more
spontaneous abortions of unknown reasons during the
first trimester. None of the women with RIF or RSA had
ever had a successful term pregnancy. Control women
delivered healthy babies at term, with one woman having
had a preterm delivery due to premature rupture of mem-
branes. None of the women included in the study had
known contributing factors for pregnancy failure, includ-
ing thrombophilia (Factor V Leiden mutation, prothrom-
bin mutation, antithrombin III, as well as protein C or S
deficiency), antiphospholipid syndrome (anticardiolipin
antibodies, lupus anticoagulans, ANAs), uterine anoma-
lies detected by ambulatory hysteroscopy, polycystic
ovarian syndrome, hormone abnormalities (thyroid, pro-
lactin etc.) and other endocrinopathies (e.g., diabetes).
On the day of biopsy blood samples were collected for
determination of estradiol-17β (E2) and progesterone
concentration in serum using a competitive immunoas-
say by the University of Heidelberg core facility. The LH
surge was determined using a commercially available
urine LH kit (Clear blue, WICK PHARMA/Procter &
Gamble GMBH, Schwalbach am Taunus, Germany). Fur-
thermore, histology of the biopsies typical for the secre-
tory phase was confirmed by two individual researchers
according to the modified Noyes' criteria [20].
Tissue preparation
Immediately after the biopsies were performed, tissues
were immersed in OCT, frozen in liquid nitrogen and
stored at -80°C. Tissues were then sectioned at 8 μm,
mounted onto SuperFrost Plus slides (Menzel GmbH &
Co, Braunschweig, Germany), fixed with 100% acetone at
4°C for 10 min, and stored at -70°C before immunohisto-
logical procedure.
Immunohistochemistry
Cell proliferation was determined based on immunolo-
calization of Ki67 protein (a marker of proliferating cells)
and vascularisation was determined by immunolocaliza-
tion of factor VIII (a marker of endothelial cells) and
SMCA (a marker of pericytes and smooth muscle cells) as
previously described [21,22]. Briefly, sections of cryopre-
served endometrial tissues were rinsed several times in
PBS containing Triton-X100 and were then treated for 20
min with blocking buffer [PBS containing normal goat
serum (1-2%, v/v)] followed by treatment with primary
antibody against Ki67 (1:100; mouse monoclonal; Vector
Laboratories, Burlingame, CA, USA), factor VIII (1:100;
rabbit polyclonal; Sigma, St. Louis, MO, USA) or SMCA
(1:150; mouse monoclonal; Oncogene Research Products;
San Diego, CA, USA) overnight at 4°C. Primary antibody
was detected using a biotin-labeled secondary antibody
(anti-mouse antibody for Ki67 and SMCA, and anti-rab-
bit antibody for factor VIII; Vector Laboratories) and the
ABC kit (Vector Laboratories). For color development,
Vector SG substrate kit (Vector Laboratories) was used.
Sections stained for the presence of Ki67 were counter-
stained with fast red (Sigma) to visualize cell nuclei. Con-
trol sections were incubated with normal mouse IgG (4
μg/mL) or rabbit IgG (diluted 1:100) in place of primary
antibody.
Image analysis
Image analysis was performed as described in detail pre-
viously [22,23]. Endometrial images of randomly chosen
areas (5-10 per uterine section/subject; 0.025 mm2 per
field) stained for Ki67, factor VIII or SMCA were taken at
400 × magnification, using the Eclipse E600 Nikon micro-
scope and digital camera. Labeling index (LI; proportion
of proliferating Ki67-postive cells out of the total cells per
area), vascularity based on relative expression of factor
VIII (occupied by endothelial cells) and SMCA (located
in smooth muscle cells and pericytes) were determined
by using computerized image analysis (Image-Pro Plus,
version 5.0; Media Cybernatics, Houston, TX, USA). For
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area that exhibited positive staining within tissue area.
Statistical Analysis
Data were analyzed using the general linear model (GLM)
procedures of SAS (SAS Inst. Inc. Cary, NC). When the
F-test was significant (P < 0.05), differences among means
were evaluated by using the least square means proce-
dure [24]. Data are expressed as mean ± SEM.
Results
The mean age of the women in the control group (30.3 ±
1.9 years) was similar to the women with RSA (34.6 ± 1.2
years) and the women with RIF (34.3 ± 0.8 years). E2 and
progesterone serum concentration were similar in con-
trol, RSA and RIF (E2: 146 ± 21, 158 ± 25 and 128 ± 11
pg/ml; progesterone: 14.4 ± 4.3, 11.0 ± 1.7 and 10.2 ± 0.8
ng/ml), respectively.
Ki67, factor VIII and SMCA were detected in uterine
tissue sections in all groups (Fig. 1 and 2). Ki67 was
detected in cells of uterine glands, stromal tissue and
blood vessels (Fig. 1A-C), while factor VIII (Fig. 2A) and
SMCA (Fig. 2B) were localized to blood vessels. Factor
VIII was detected in small and larger blood vessels (Fig.
2A), and SMCA was detected mostly in the larger blood
vessels, but also in some small blood vessels (Fig. 2B).
The labeling index was greater (P < 0.0004) in endome-
trium of the control group compared to the endometrium
of women with RSA or RIF, which were both similar (Fig.
3). The cell proliferation index of the different groups was
not significantly correlated to the estrogen serum con-
centration (P = 0.369). The expression of factor VIII or
SMCA in endometrium was similar in all three groups
(Fig. 3).
Discussion
The present data demonstrates that in two pathological
groups, RSA and RIF cellular proliferation is less than in a
control group. However, vascularisation of endometrium
in these pathological groups was similar to the control
group.
Although it is widely accepted that the quality of the
embryo is the essential factor for successful pregnancy
outcome, several studies have shown the importance of
endometrial function in successful pregnancy outcome
[5,14,25]. Numerous studies have focused on causes of
implantation failures by examining embryo effects or
endometrium at cellular and molecular levels
[8,11,12,26,27]. The function of the endometrium is to
allow implantation on one hand, but make sure that inva-
sion of the uterine tissue is limited, as otherwise inade-
quate placentation occurs, including placenta accreta,
increta, percreta [28]. Furthermore, endometrial cell pro-
liferation and differentiation has to be tightly controlled
[14], as progression to endometrial cancer can be seen
when uninhibited proliferation takes place [29]. In the
present study, inadequate endometrial growth marked by
reduced cell proliferation in endometrium could contrib-
ute to reproductive failure. Although very few studies
investigated endometrial cell proliferation and its regula-
tory mechanisms, decreased proliferation is found in
endometrium at the time of menopausal transition in
women [30], while in endometriosis, cellular proliferation
in the human endometrium was enhanced around the
time of implantation and during late secretory phase [31].
Furthermore, Mertens et al have described ongoing tissue
proliferation of endometrial stromal cells via Ki67 expres-
sion in the secretory phase despite rising progesterone
levels [32]. In agreement with our results, Lee and col-
leges [11] have indicated that defective cell growth, regu-
lated by the differentially expressed genes controlling the
cell cycle, is likely to contribute to implantation failure.
Numerous growth factors of uterine tissues including
fibroblast growth factors, epidermal growth factors, vas-
cular endothelial growth factor and others are involved in
the control of endometrial growth and function [33,34].
In addition, estrogens and progesterone are also impor-
tant regulators of endometrial function [15,35]. However,
in our study as well as in other studies, concentration of
E2 and progesterone were similar in normal and patho-
logical conditions [36]. This suggests that inadequate
expression of growth factor(s), rather than steroid hor-
mones contributed to decrease the cell proliferation in
reproductive failure cases. Nevertheless the effect of ste-
roid hormones cannot be excluded, since a difference in
distribution of nuclear and cytoplasmic progesterone
receptors was found in women with early pregnancy loss
compared to women with proven fertility [36]. In addi-
tion, the progesterone receptor is thought to play a role in
the implantation defect of women with RIF [37]. Last but
not least a reduction of estrogen receptor alpha at the
time of implantation is described in women with RIF [10].
Therefore, further investigation is needed to evaluate the
potential impact of the changes in hormone receptors on
endometrial cell proliferation in women with reproduc-
tive failure.
Since cellular proliferation is reflected by tissue growth
and development, endometrial thickness and/or volume
is likely to depend on the rate of cell proliferation at spe-
cific reproductive stages. In fact, several studies have
demonstrated a positive association between pregnancy
rate and endometrial volume and/or thickness [38,39].
Thus, these observations are in agreement with our data
showing reduced cell proliferation in reproductive fail-
ures. On the other hand, several studies did not observe
any association between endometrial volume or endome-
trial thickness and pregnancy outcome [16,40]. These dis-
crepancies are likely due to different timing and
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volume or thickness. Therefore, more detailed and uni-
formed studies should be performed to determine the
role of endometrial cell proliferation, volume and thick-
ness in reproductive failure.
In the present study, we demonstrated that vasculariza-
tion of endometrium was similar for controls and women
with reproductive failure, indicating a limited role of
blood vessel function in implantation failure. In agree-
ment to our study, Plaisier et al also showed no difference
in vascularisation on the maternal side of implantation,
namely decidualized endometrial stromal cells, in cases
with missed abortions compared to controls, while they
were able to demonstrated differences in receptors of
growth factors in decidua parietalis and basalis at the
time of missed abortion [41]. Although the importance of
angiogenesis for implantation, and normal uterine and
placental function is well recognized [16,42,43], the role
of inadequate vascularization or blood flow in implanta-
tion failure has not been investigated in detail. Inconsis-
tent results of impact of uterine blood flow in
implantation failure measured by ultrasound technolo-
gies were obtained [16,17]. For example, using ultrasound
techniques [44], reduced endometrial and subendome-
trial 'perfusion' has been demonstrated which suggests a
reduced vascularity in women with unexplained subfer-
itility, irrespective of E2 and progesterone levels. In con-
trast, Ng et al. [45,46] did not find any association
between infertility and blood flow measured via ultra-
sound techniques. These latest results are in agreement
Figure 1 Immunohistochemical staining of Ki67. Representative micrographs of positive staining of Ki67 in human endometrium obtained from 
healthy women (A), and women with RSA (B) or RIF (C). Dark staining indicates proliferating cells, and pink staining indicates cell nuclei of non-prolif-
erating cells. Note more proliferating cells in A than in B or C. Proliferating cells in endometrial glands are marked with small arrows in A and B, and in 
stromal tissue with large arrows in A, B and C. Insert in C demonstrated proliferating cells in a blood vessel. Endometrial glands are marked with stars 
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blood vessel density in reproductive failure subjects. The
discrepancies of results in studies cited above are likely
due to different techniques (ultrasound vs. immunohis-
tochemisty and image analysis), different population and/
or study design used in these experiments. Since human
studies are restricted in their design, the studies per-
formed in human tissue are limited in their character,
therefore we were only able to look at the intrinsic endo-
metrial regulation of women with reproductive failure at
the protein level. Thus, additional studies should be per-
formed to determine mRNA and protein expression espe-
cially for genes regulating cell proliferation in
endometrium from women with and without reproduc-
tive failure.
Conclusion
In summary, we demonstrate a decrease in cell prolifera-
tion in endometrial tissues from the mid-secretory phase
in women with reproductive failure compared to healthy
controls. However, vascularisation in endometrium was
similar for the examined groups. We therefore hypothe-
size that adequate endometrial growth is a critical factor
contributing to the success of implantation, as well as fur-
ther continuation of an established pregnancy. Our
results help to better understand the underlying path-
omechanism of reproductive failure and may contribute
to a discovery of marker(s) which can be used to predict
successful vs. non-successful pregnancy.
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